Laurent-Dominique Piveteau joined Debiotech in 2005 and was appointed as Chief Executive Officer in 2015. Prior to this, Dr Piveteau held several positions in R&D and in business development. He developed a coating for bone implants in collaboration with the Robert Mathys Foundation, he was a researcher at MIT (Cambridge, MA, US) working on contrast media for MRI, and worked in technology transfer at the Swiss Federal Institute of Technology in Lausanne (EPFL) (Switzerland). In parallel to his current position, Dr Piveteau also teaches Innovation Economics at EPFL. He holds an MSc in Physics from the ETH Zürich (Switzerland), a PhD from the University of Fribourg (Switzerland) and an MBA from INSEAD in Singapore and Fontainebleau (France).